To further investigate whether plasma IGF-I, IGF-II, and IGFBP-3 levels are associated with the risk of pancreatic cancer, we performed a nested case–control study using the combined resources of four large prospective cohort studies, with blood samples collected before cancer diagnosis. This evidence concerns the gene IGF1 and cancer.